» Articles » PMID: 20117104

Complete Blood Count, Measures of Iron Status and Inflammatory Markers in Inner-city African Americans with Undiagnosed Hepatitis C Seropositivity

Overview
Journal Clin Chim Acta
Specialty Biochemistry
Date 2010 Feb 2
PMID 20117104
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatitis C virus (HCV) infection may be associated with thrombocytopenia and increased iron stores in patients receiving medical care. We aimed to determine how often changes in hematologic, iron metabolic and inflammatory markers occur in individuals with undiagnosed HCV in the community.

Methods: Inner-city African Americans (n=143) were recruited from the community according to reported ingestion of alcohol. They were divided broadly into those who drank more or less than 56 g alcohol/day as assessed by dietary questionnaire. HCV serology was determined and laboratory values were compared according to HCV seropositivity in analyses that adjusted for alcohol consumption.

Results: The prevalence of HCV seropositivity was 23% among men and 29% among women. Levels of hepatocellular enzymes were higher with HCV seropositivity (P<0.0001) but hemoglobin concentrations, white blood cell and platelet counts and serum ferritin concentrations did not differ. The globulin fraction of the serum protein concentration (P=0.002) was increased with HCV seropositivity as expected with chronic inflammation. However, erythrocyte sedimentation rate and serum iron and haptoglobin levels did not differ significantly according to HCV status. Furthermore, multivariate analysis revealed that C-reactive protein was decreased and transferrin concentration was increased with both HCV and alcohol consumption (P<0.014).

Conclusions: Previously undiagnosed HCV seropositivity has little effect on the complete blood count and body iron stores but appears to perturb the response to an inflammatory stimulus, causing reduced rather than increased circulating CRP concentrations and increased rather than decreased transferrin concentrations.

Citing Articles

Laboratory Biochemical and Hematological Parameters: Early Predictive Biomarkers for Diagnosing Hepatitis C Virus Infection.

Bagheri S, Fard G, Talkhi N, Rashidi Zadeh D, Mobarra N, Mousavinezhad S J Clin Lab Anal. 2024; 38(24):e25127.

PMID: 39569979 PMC: 11659729. DOI: 10.1002/jcla.25127.


Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review.

Babiker A, Hassan M, Muhammed S, Taylor G, Poonia B, Shah A Clin Cardiol. 2019; 43(3):222-234.

PMID: 31785111 PMC: 7068107. DOI: 10.1002/clc.23299.


Abnormal serum iron markers in chronic hepatitis B virus infection may be because of liver injury.

Mao W, Hu Y, Lou Y, Chen Y, Zhang J Eur J Gastroenterol Hepatol. 2014; 27(2):130-6.

PMID: 25419642 PMC: 4280275. DOI: 10.1097/MEG.0000000000000247.


Coinfection with HIV-1 alleviates iron accumulation in patients with chronic hepatitis C virus infection.

Liu Y, Lv Q, Gao J, Long L, Duan Z, Liang H PLoS One. 2014; 9(6):e98039.

PMID: 24927015 PMC: 4057081. DOI: 10.1371/journal.pone.0098039.

References
1.
Pyrsopoulos N, Jeffers L . Hepatitis C in African Americans. J Clin Gastroenterol. 2007; 41(2):185-93. DOI: 10.1097/01.mcg.0000225689.60335.44. View

2.
Andrews N . Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest. 2004; 113(9):1251-3. PMC: 398435. DOI: 10.1172/JCI21441. View

3.
McHutchison J, Dusheiko G, Shiffman M, Rodriguez-Torres M, Sigal S, Bourliere M . Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med. 2007; 357(22):2227-36. DOI: 10.1056/NEJMoa073255. View

4.
Mengshol J, Golden-Mason L, Rosen H . Mechanisms of Disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol. 2007; 4(11):622-34. DOI: 10.1038/ncpgasthep0961. View

5.
Etienne A, Gayet S, Vidal F, Poullin P, Brunet C, Harle J . Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: efficacy and safety of anti-CD20 (rituximab) treatment. Am J Hematol. 2004; 75(4):243-5. DOI: 10.1002/ajh.20004. View